Biliary Liver Cirrhosis, Cholelithiasis
Ursodeoxycholic acid is used to treat primary biliary cholangitis, which is a disease that damages the bile ducts in the liver. It helps improve liver function and can also be used for other liver conditions as determined by your doctor.
Ursodeoxycholic acid works by reducing cholesterol production and dissolving cholesterol in bile, which helps improve liver function. It acts like a detergent that breaks down fats, clearing bile from the liver and reducing liver damage.
The usual starting dose for adults is 8-10 mg per kilogram of body weight per day, divided into two or three doses. It's taken with meals, and tablets should be swallowed whole with water. Your doctor may adjust the dose based on your response.
Common side effects include diarrhea, nausea, and abdominal pain, which are usually mild. These effects may improve as your body adjusts to the medication. If you experience severe or persistent symptoms, consult your doctor.
Do not take Ursodeoxycholic acid if you have a complete bile duct blockage or certain liver conditions. Caution is needed during pregnancy and breastfeeding. Always inform your doctor about your medical history before starting this medication.
US(FDA), UK(BNF)
NO
NO
Bile Acid
NO
Ursodeoxycholic acid (UDCA) is primarily used to treat certain liver conditions, such as primary biliary cholangitis and gallstones. It works by reducing the production of cholesterol in the liver and improving bile flow, which helps dissolve gallstones and prevents the buildup of toxic bile acids. UDCA also has a protective effect on liver cells, promoting liver health.
Ursodeoxycholic acid works by reducing the production of cholesterol in the liver and improving bile flow. It helps to dissolve cholesterol-based gallstones by decreasing the cholesterol content of bile. In liver diseases, it protects liver cells by reducing the toxicity of bile acids, promoting liver function, and decreasing inflammation. This results in improved bile circulation and liver health.
Several clinical trials have shown that Tetrabenazine can be an effective treatment for Huntington's disease and other neurological conditions. Tetrabenazine has been found to significantly reduce chorea and tardive dyskinesia in several trials, demonstrating its potential to provide relief to patients suffering from these conditions.
Ursodeoxycholic acid should be taken with food to enhance absorption and reduce potential gastrointestinal irritation. There are no specific food restrictions while using this medication, but it is recommended to maintain a balanced diet. Patients should avoid taking the medication with antacids containing aluminum hydroxide, as they can interfere with its effectiveness. Always follow the dosage instructions provided by the healthcare provider.
Ursodeoxycholic acid can take several weeks to months to show noticeable effects, depending on the condition being treated. For example, in patients with gallstones, it may take 6 to 12 months to dissolve the stones completely. For liver diseases like primary biliary cholangitis, improvements in liver function may be seen within 3 to 6 months, but full benefits may take longer.
Ursodeoxycholic Acid should be stored at room temperature, between 68°F and 77°F (20°C and 25°C). The medication should be kept in a tightly closed container, away from light, heat, and moisture.
UDCA can cause severe diarrhea, nausea, and vomiting in some patients. If these symptoms occur, contact your doctor immediately.
UDCA can cause liver damage in patients with advanced cirrhosis or other severe liver disease.
UDCA can increase the risk of bleeding, particularly in patients with a history of bleeding disorders or who are taking blood-thinning medications.
UDCA can interact with statins and increase the risk of liver damage.
UDCA can interact with blood-thinning medications and increase the risk of bleeding.
UDCA can interact with certain antibiotics and reduce their effectiveness.
Ursodeoxycholic Acid (UDCA) is generally considered safe for use during pregnancy. Animal studies have not shown any evidence of harm to the fetus, and there is limited data available from human studies. However, UDCA should only be used during pregnancy if the benefits to the mother outweigh the risks to the fetus.
Ursodeoxycholic Acid (UDCA) can pass into breast milk, and it's not known if it can harm a nursing baby. However, it's generally considered safe for breastfeeding mothers to take UDCA.
Women who are breastfeeding and need to take UDCA should monitor their baby closely for any signs of side effects, such as diarrhea, vomiting, or poor weight gain.